Service & Payment Policy

Effective Date: [10.31.2025]

This Service & Payment Policy outlines the terms governing commercial engagements with NAMina Bio Corp. (“NAMina Bio,” “we,” “us,” or “our”).

​

1. Scope of Services

NAMina Bio provides scientific and strategic services, including but not limited to:

• Experimental design and translational program development

• Advanced in vitro modeling (e.g., organoids, 3D bioprinting, microphysiological systems)

• Data analysis and interpretation

• Platform integration and pilot studies

All services are customized and project-specific.

The exact scope, deliverables, timelines, and pricing are defined in formal written agreements, such as:

• Proposals

• Statements of Work (SOW)

• Master Service Agreements (MSA)

• Pilot agreements

​

2. Proposal and Acceptance

Quotes and proposals provided by NAMina Bio:

• Are non-binding until formally accepted

• May include defined milestones, timelines, and deliverables

Work begins only after:

• Written acceptance of the proposal or agreement

• Completion of any required onboarding steps (e.g., NDA, data access, sample logistics)

​

3. Payment Terms

Unless otherwise specified in writing:

• Payments may be structured as:

  • Upfront fees

  • Milestone-based payments

  • Retainers or pilot program fees

• Invoices are payable within [e.g., 15 or 30 days] from the issue date

• Late payments may result in:

  • Suspension of work

  • Delays in deliverables

​

4. Non-Refundable Work

Due to the custom and scientific nature of our services:

• Fees are generally non-refundable once work has commenced

• This includes:

  • Experimental design and planning

  • Resource allocation and setup

  • Data generation and analysis

  • Partner coordination and integration

Partial refunds, if any, are:

• Evaluated on a case-by-case basis

• Limited to work not yet performed

​

5. Changes in Scope

Any modification to the agreed scope (e.g., additional experiments, extended timelines, new endpoints):

• Must be mutually agreed in writing

• May result in revised pricing and timelines

NAMina Bio is not obligated to proceed with out-of-scope work without formal approval.

​

6. Client Responsibilities

Clients are responsible for:

• Providing accurate and complete information

• Ensuring proper authorization for data or materials shared

• Complying with applicable regulations and ethical requirements

Delays caused by missing or incomplete inputs may affect timelines and costs.

​

7. Data and Deliverables

All deliverables are defined within the applicable agreement.

• Preliminary, draft, or exploratory outputs may be subject to revision

• Final deliverables are provided upon fulfillment of payment obligations

Use of data beyond the agreed scope requires:

• Explicit written authorization

• Applicable data use agreements (DUAs), where relevant

​

8. Cancellation

Projects may be canceled:

• By mutual written agreement, or

• Under conditions defined in the governing contract

In case of cancellation:

• Clients remain responsible for payment of work already performed

• Any prepaid but unused portion may be evaluated for partial credit (not guaranteed)

​

9. No Guarantee of Outcome

Due to the nature of scientific research:

• NAMina Bio does not guarantee specific experimental, clinical, or commercial outcomes

• Results may vary based on biological variability, model limitations, and external factors

​

10. Governing Agreements

In the event of any conflict between this Policy and a signed agreement (e.g., MSA, SOW):

The signed agreement takes precedence

​

11. Contact Information

For questions regarding this policy:

NAMina Bio Corp.
[45-18 Court Sq W Long Island City, 11101 NY– BioLabs@NYU Langone]
[paoladama@naminabioscience.com]